Preeclampsia and Angiogenic Imbalance

作者：Sharon E. Maynard, Franklin H. Epstein, S. Ananth Karumanchi · 发表于：Annual Review of Medicine · 年份：2007 · DOI：10.1146/annurev.med.59.110106.214058 · 被引用次数：335 · 研究领域：Pregnancy and preeclampsia studies、Reproductive System and Pregnancy、Birth, Development, and Health

Preeclampsia is a systemic syndrome of pregnancy that originates in the placenta and is characterized by widespread maternal endothelial dysfunction. Until recently, the molecular pathogenesis of preeclampsia was largely unknown, but recent work suggests a key role for altered expression of placental antiangiogenic factors. Soluble Flt1 and soluble endoglin, secreted by the placenta, are increased in the maternal circulation weeks before the onset of preeclampsia. These antiangiogenic factors produce systemic endothelial dysfunction, resulting in hypertension, proteinuria, and the other systemic manifestations of preeclampsia. The molecular basis for placental dysregulation of these pathogenic factors remains unknown, and the role of angiogenic proteins in early placental vascular development is just beginning to be explored. These discoveries have exciting clinical implications and are likely to transform the detection and treatment of preeclampsia in the future.